The human lung biomolecular multi-scale atlas program (hubmap-lung)

Active Cooperative Agreement Awarded Last action

Award ID
U54HL165443
Recipient
Awarding agency
Obligated
$15,289,533

Award facts

Assistance listing
93.310 Trans-NIH Research Support
Completion date 83% complete
Originally
Funding agency
Office of the Director National Institutes of Health, Department of Health and Human Services
Place of performance
Rochester, NY 14642, USA

Award details come from USAspending.gov.

Description

Abstract
Overall research plan the human lung biomolecular multi-scale atlas program (hubmap-lung) the human biomolecular atlas program (hubmap) is entering the production phase, with an emphasis on progressive, high sensitivity and specificity assays, prioritizing spatial biomolecular analysis. Our tissue mapping center (TMC) proposal will focus on one organ system, comprised of two lungs and related respiratory tract (trachea to alveoli) that for simplicity we refer to as the "lung". Our TMC will generate, standardize, and validate extensive data from high content, high-throughput imaging and `omics technology to produce systematic human lung tissue maps at high resolution. We will take a long view of an atlas, as a collection of 2D and 3D maps containing images, tabular data, facts about multiple locations at varying resolution, and indexes of named objects keyed to coordinates of a locational grid analogous to latitude and longitude, to cartographically present the whole range of salient features of the human lung. To accomplish this task, our center brings together investigators from five institutions, the university of rochester (urmc), university of california at SAN diego (ucsd), pacific northwest national laboratory (pnnl), university of washington (UW), and university of north carolina at chapel hill (UNC), each with complementary lung-focused academic interests, knowledge, and inter- consortia network connections and with internationally recognized expertise in lung and state-of-the-art biomolecular technologies. Our lung data provided to the hubmap data portal in phase i has been focused to single nucleus RNA-sequencing, chromatin availability and beginning spatial transcriptomics. In addition to further increasing representation of human diversity in these data types, the next phase of our TMC turns primary effort toward determining spatial organization of cells and matrices defined by not only gene expression but also proteins, protein modifications, lipids and select metabolites critical to specific cell function within anatomical and functional niches. With the recognized value of global investigative efforts within and outside the consortium, the specific aims of the TMC overall component concentrate on communication and collaboration within the TMC, between all hubmap components and synergistically among national and international researchers and consortia.

Transactions

Action Obligated Date
Amendment $0
Amendment $0
Amendment $0
Amendment $500,000
Amendment $0
Amendment $0
Amendment $2,500,000
Amendment $2,500,000
Amendment $199,533
Amendment $90,000
Amendment $2,500,000
Amendment $2,500,000
Amendment $2,250,000
Original award $2,250,000
Show all 14

Subawards

Subrecipient Amount Awarded
The University Of Queensland AIM-for-RA $188,431
National Disease Research Interchange The Human Lung BioMolecular Multi-Scale Atlas Program (HuBMAP-Lung) $315,781
Battelle Memorial Institute $1,253,342
Seattle Children's Hospital Seattle Children's Hospital will apply expertise in lung development and disease to provide diagnostic and quality assessments of all donor lungs used by the… $103,210
University Of North Carolina At Chapel Hill The Human Lung BioMolecular Multi-Scale Atlas Program (HuBMAP-Lung) (OSP) $334,914
University Of California, San Diego The Human Lung BioMolecular Multi-Scale Atlas Program (HuBMAP-Lung) $1,039,660
University Of California, San Diego $1,329,637

Quick answers

Who received award U54HL165443?

U54HL165443 was awarded to University Of Rochester by National Heart Lung and Blood Institute (National Institutes of Health) on September 1, 2022.

How much is award U54HL165443 worth?

$15,289,533 has been obligated on U54HL165443.

Which agency awarded U54HL165443?

National Heart Lung and Blood Institute (National Institutes of Health) awarded U54HL165443, with funding from Office of the Director (National Institutes of Health).

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award